277 related articles for article (PubMed ID: 24227537)
1. The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.
Gaudio A; Privitera F; Pulvirenti I; Canzonieri E; Rapisarda R; Fiore CE
Diab Vasc Dis Res; 2014 Jan; 11(1):48-52. PubMed ID: 24227537
[TBL] [Abstract][Full Text] [Related]
2. Improved carotid intima-media thickness-induced high-intensity interval training associated with decreased serum levels of Dkk-1 and sclerostin in type 2 diabetes.
Ghardashi-Afousi A; Davoodi M; Hesamabadi BK; Asvadi-Fard M; Bigi MAB; Izadi MR; Gaeini AA
J Diabetes Complications; 2020 Jan; 34(1):107469. PubMed ID: 31706805
[TBL] [Abstract][Full Text] [Related]
3. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study.
Yang HY; Wu DA; Chen MC; Hsu BG
Diab Vasc Dis Res; 2019 May; 16(3):281-288. PubMed ID: 30547685
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
[TBL] [Abstract][Full Text] [Related]
5. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
[TBL] [Abstract][Full Text] [Related]
6. Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications.
Yang CY; Chang ZF; Chau YP; Chen A; Yang WC; Yang AH; Lee OK
Nephrol Dial Transplant; 2015 Aug; 30(8):1356-63. PubMed ID: 25817223
[TBL] [Abstract][Full Text] [Related]
7. Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania.
Gaudio A; Fiore V; Rapisarda R; Sidoti MH; Xourafa A; Catalano A; Tringali G; Zanoli L; Signorelli SS; Fiore CE
Mol Med Rep; 2017 May; 15(5):3420-3424. PubMed ID: 28339088
[TBL] [Abstract][Full Text] [Related]
8. Serum sclerostin level and its relation to subclinical atherosclerosis in subjects with type 2 diabetes.
Shalash MAM; Rohoma KH; Kandil NS; Abdel Mohsen MA; Taha AAF
J Diabetes Complications; 2019 Aug; 33(8):592-597. PubMed ID: 31129005
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients.
Göbel A; Kuhlmann JD; Link T; Wimberger P; Browne AJ; Rauner M; Hofbauer LC; Rachner TD
Breast Cancer Res Treat; 2017 Aug; 164(3):737-743. PubMed ID: 28526959
[TBL] [Abstract][Full Text] [Related]
10. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
[TBL] [Abstract][Full Text] [Related]
11. Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes.
Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Tsanikidis H; Vitta I; Karkos C; Karayannacos PE; Gerasimidis T; Liapis CD
Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):75-80. PubMed ID: 19834878
[TBL] [Abstract][Full Text] [Related]
12. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.
Gifre L; Ruiz-Gaspà S; Monegal A; Nomdedeu B; Filella X; Guañabens N; Peris P
Bone; 2013 Nov; 57(1):272-6. PubMed ID: 23981659
[TBL] [Abstract][Full Text] [Related]
13. Antagonists of Wnt/β-catenin signalling in the periodontitis associated with type 2 diabetes and smoking.
Miranda TS; Napimoga MH; Feres M; Marins LM; da Cruz DF; da Silva HDP; Duarte PM
J Clin Periodontol; 2018 Mar; 45(3):293-302. PubMed ID: 29243300
[TBL] [Abstract][Full Text] [Related]
14. High serum levels of sclerostin and Dickkopf-1 are associated with acute ischaemic stroke.
He XW; Wang E; Bao YY; Wang F; Zhu M; Hu XF; Jin XP
Atherosclerosis; 2016 Oct; 253():22-28. PubMed ID: 27573735
[TBL] [Abstract][Full Text] [Related]
15. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
[TBL] [Abstract][Full Text] [Related]
16. Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective study.
Gifre L; Vidal J; Carrasco JL; Filella X; Ruiz-Gaspà S; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
J Bone Miner Res; 2015 Jun; 30(6):1014-21. PubMed ID: 25484108
[TBL] [Abstract][Full Text] [Related]
17. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
Anastasilakis AD; Polyzos SA; Gkiomisi A; Bisbinas I; Gerou S; Makras P
J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients.
Chang YC; Hsu BG; Liou HH; Lee CJ; Wang JH
BMC Cardiovasc Disord; 2018 Nov; 18(1):214. PubMed ID: 30482161
[TBL] [Abstract][Full Text] [Related]
19. Association between serum and synovial fluid Dickkopf-1 levels with radiographic severity in primary knee osteoarthritis patients.
Theologis T; Efstathopoulos N; Nikolaou V; Charikopoulos I; Papapavlos I; Kokkoris P; Papatheodorou A; Nasiri-Ansari N; Kassi E
Clin Rheumatol; 2017 Aug; 36(8):1865-1872. PubMed ID: 28451870
[TBL] [Abstract][Full Text] [Related]
20. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
